皮肤基底细胞癌诊疗专家共识（2021）

doi:10.35541/cjd.20201139

摘要/Abstract

摘要： 【摘要】皮肤基底细胞癌是最常见的皮肤恶性肿瘤，生长缓慢，较少转移，但高危型可破坏组织和器官，甚至危及患者生命。本文在国内外近期文献及诊疗指南的基础上，结合我国诊疗现状，综合多学科专家意见，重点阐述皮肤基底细胞癌的临床表现、诊断、风险评估及治疗，以形成我国基底细胞癌诊疗专家共识，为临床规范化诊疗提供参考依据。

关键词: 癌, 基底细胞, 诊断, 治疗, 专家共识

Abstract: 【Abstract】 Basal cell carcinoma （BCC） is the most common malignant skin tumor. It is slow-growing and less likely to metastasize, but the high-risk subtype can destroy tissues and organs, and even endanger patients′ lives. Based on the recent domestic and international literature and guidelines, and combining with the current status of diagnosis and treatment of BCC in China and multidisciplinary expert opinions, this article focuses on clinical manifestations, diagnosis, risk assessment and treatment of cutaneous BCC, aiming to form an expert consensus on the diagnosis and treatment of cutaneous BCC in China and provide a reference for standardized diagnosis and treatment in clinical practice.

Key words: Carcinoma, basal cell, Diagnosis, Treatment, Expert consensus

中华医学会皮肤性病学分会皮肤肿瘤研究中心中国医师协会皮肤科医师分会皮肤肿瘤学组. 皮肤基底细胞癌诊疗专家共识（2021）[J]. 中华皮肤科杂志, 2021, 54(9): 757-764.doi:10.35541/cjd.20201139

Skin Tumor Research Center, Chinese Society of Dermatology, Subcommittee on Skin Tumor, China Dermatologist Association. Expert consensus on diagnosis and treatment of cutaneous basal cell carcinoma （2021）[J]. Chinese Journal of Dermatology, 2021, 54(9): 757-764.doi:10.35541/cjd.20201139

参考文献 39

［1］	Peris K, Fargnoli MC, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma: European consensus⁃based interdisciplinary guidelines［J］. Eur J Cancer, 2019,118:10⁃34. doi: 10.1016/j.ejca.2019.06.003.
［2］	Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016［J］. Lancet, 2018,391（10136）:2236⁃2271. doi: 10.1016/S0140⁃6736（18）30994⁃2.
［3］	Wu S, Han J, Li WQ, et al. Basal⁃cell carcinoma incidence and associated risk factors in U.S. women and men［J］. Am J Epidemiol, 2013,178（6）:890⁃897. doi: 10.1093/aje/kwt073.
［4］	涂庆峰, 吕婷, 赖永贤, 等. 上海市某社区老年人皮肤肿瘤流行病学研究［J］. 老年医学与保健, 2013,19（3）:142⁃145,148. doi: 10.3969/j.issn.1008⁃8296.2013⁃05.
［5］	郑博文, 邹勇莉, 何黎, 等. 皮肤恶性肿瘤568例回顾性分析［J］. 中国皮肤性病学杂志, 2009,23（12）:808⁃809,818.
［6］	黄远深, 李航, 涂平, 等. 632例皮肤恶性肿瘤及癌前病变临床分析［J］. 中华皮肤科杂志, 2010,43（7）:452⁃454. doi: 10. 3760/cma.j.issn.0412⁃4030.2010.07.002.
［7］	陈娜, 张良, 陈柳青. 皮肤恶性肿瘤及癌前病变3163例临床分析［J］. 临床皮肤科杂志, 2020,49（8）:456⁃459. doi: 10. 16761/j.cnki.1000⁃4963.2020.08.004.
［8］	陈自学, 周美杉, 涂平, 等. 418例基底细胞癌病例临床病理特点回顾分析［J］. 北京大学学报（医学版）, 2014,46（2）:195⁃199. doi: 10.3969/j.issn.1671⁃167X.2014.02.004.
［9］	高蓉梅. 109例皮肤基底细胞癌临床病理特点分析［J］. 医药前沿, 2018,8（3）:74⁃75.
［10］	McKenzie CA, Chen AC, Choy B, et al. Classification of high risk basal cell carcinoma subtypes: experience of the ONTRAC study with proposed definitions and guidelines for pathological reporting［J］. Pathology, 2016,48（5）:395⁃397. doi: 10.1016/j.pathol.2016.05.005.
［11］	Zanetti R, Rosso S, Martinez C, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi⁃centre case⁃case⁃control study［J］. Br J Cancer, 2006,94（5）:743⁃751. doi: 10.1038/sj.bjc.6602982.
［12］	Bonilla X, Parmentier L, King B, et al. Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma［J］. Nat Genet, 2016,48（4）:398⁃406. doi: 10. 1038/ng.3525.
［13］	Jayaraman SS, Rayhan DJ, Hazany S, et al. Mutational landscape of basal cell carcinomas by whole⁃exome sequencing［J］. J Invest Dermatol, 2014,134（1）:213⁃220. doi: 10.1038/jid.2013.276.
［14］	Bresler SC, Padwa BL, Granter SR. Nevoid basal cell carcinoma syndrome （Gorlin syndrome）［J］. Head Neck Pathol, 2016,10（2）:119⁃124. doi: 10.1007/s12105⁃016⁃0706⁃9.
［15］	AlSabbagh MM, Baqi MA. Bazex⁃Dupré⁃Christol syndrome: review of clinical and molecular aspects［J］. Int J Dermatol, 2018,57（9）:1102⁃1106. doi: 10.1111/ijd.14065.
［16］	中国中西医结合学会皮肤性病专业委员会皮肤影像学组, 中国医疗保健国际交流促进会皮肤科分会皮肤影像学组, 中华医学会皮肤性病学分会皮肤病数字化诊断亚学组, 等. 中国基底细胞癌皮肤镜特征专家共识（2019）［J］. 中华皮肤科杂志, 2019,52（6）:371⁃377. doi: 10.3760/cma.j.issn.0412⁃4030. 2019.06.001.
［17］	中华医学会皮肤性病学分会皮肤肿瘤研究中心, 中国医师协会皮肤科医师分会皮肤肿瘤学组. 皮肤鳞状细胞癌规范化诊疗共识（2021）［J］. 中华皮肤科杂志, 2021,54（8）:653⁃664. doi: 10.35541/cjd.20201140.
［18］	National Comprehensive Cancer Network. Basal cell skin cancer, version 2.2021, NCCN clinical practice guidelines in oncology［Z/OL］. （2021⁃02⁃25）［2021⁃07⁃01］. https://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf.
［19］	Tanese K. Diagnosis and management of basal cell carcinoma［J］. Curr Treat Options Oncol, 2019,20（2）:13. doi: 10.1007/s11864⁃019⁃0610⁃0.
［20］	Smeets NW, Krekels GA, Ostertag JU, et al. Surgical excision vs Mohs′ micrographic surgery for basal⁃cell carcinoma of the face: randomised controlled trial［J］. Lancet, 2004,364（9447）:1766⁃1772. doi: 10.1016/S0140⁃6736（04）17399⁃6.
［21］	Van Loo E, Mosterd K, Krekels GA, et al. Surgical excision versus Mohs′ micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow⁃up［J］. Eur J Cancer, 2014,50（17）:3011⁃3020. doi: 10.1016/j.ejca.2014. 08.018.
［22］	Mosterd K, Krekels GA, Nieman FH, et al. Surgical excision versus Mohs′ micrographic surgery for primary and recurrent basal⁃cell carcinoma of the face: a prospective randomised controlled trial with 5⁃years′ follow⁃up［J］. Lancet Oncol, 2008,9（12）:1149⁃1156. doi: 10.1016/S1470⁃2045（08）70260⁃2.
［23］	李媛媛, 池丽俏. 手术切除治疗皮肤恶性肿瘤的效果与复发率分析［J］. 中国肿瘤临床与康复, 2020,27（5）:575⁃578. doi: 10.13455/j.cnki.cjcor.2020.05.17.
［24］	王彦. 慢Mohs显微外科手术治疗皮肤基底细胞癌的临床观察［J］. 中国医疗美容, 2019,9（7）:39⁃42. doi: 10.19593/j.issn.2095⁃0721.2019.07.010.
［25］	Tchanque⁃Fossuo CN, Eisen DB. A systematic review on the use of cryotherapy versus other treatments for basal cell carcinoma［J］. Dermatol Online J, 2018, 24（11）. doi: 10.5070/D32411042000.
［26］	Bath⁃Hextall F, Ozolins M, Armstrong SJ, et al. Surgical excision versus imiquimod 5% cream for nodular and superficial basal⁃cell carcinoma （SINS）: a multicentre, non⁃inferiority, randomised controlled trial［J］. Lancet Oncol, 2014,15（1）:96⁃105. doi: 10. 1016/S1470⁃2045（13）70530⁃8.
［27］	Ferreres JR, Macaya A, Jucgla A, et al. Hundreds of basal cell carcinomas in a Gorlin⁃Goltz syndrome patient cured with imiquimod 5% cream［J］. J Eur Acad Dermatol Venereol, 2006,20（7）:877⁃878. doi: 10.1111/j.1468⁃3083.2006.01552.x.
［28］	Miller BH, Shavin JS, Cognetta A, et al. Nonsurgical treatment of basal cell carcinomas with intralesional 5⁃fluorouracil/epinephrine injectable gel［J］. J Am Acad Dermatol, 1997,36（1）:72⁃77. doi: 10.1016/s0190⁃9622（97）70328⁃1.
［29］	Kowalzick L, Rogozinski T, Wimheuer R, et al. Intralesional recombinant interferon beta⁃1a in the treatment of basal cell carcinoma: results of an open⁃label multicentre study［J］. Eur J Dermatol, 2002,12（6）:558⁃561.
［30］	Kaplan B, Moy RL. Effect of perilesional injections of PEG⁃interleukin⁃2 on basal cell carcinoma［J］. Dermatol Surg, 2000, 26（11）:1037⁃1040. doi: 10.1046/j.1524⁃4725.2000.0260111037.x.
［31］	Glass LF, Jaroszeski M, Gilbert R, et al. Intralesional bleomycin⁃mediated electrochemotherapy in 20 patients with basal cell carcinoma［J］. J Am Acad Dermatol, 1997,37（4）:596⁃599. doi: 10.1016/s0190⁃9622（97）70178⁃6.
［32］	Wang H, Xu Y, Shi J, et al. Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta⁃analysis［J］. Photodermatol Photoimmunol Photomed, 2015,31（1）:44⁃53. doi: 10.1111/phpp.12148.
［33］	任媛, 王元元, 张军波, 等. 局部光动力疗法治疗皮肤恶性肿瘤的远期疗效评价［J］. 重庆医学, 2017,46（10）:1373⁃1374. doi: 10.3969/j.issn.1671⁃8348.2017.10.025.
［34］	Soleymani T, Abrouk M, Kelly KM. An analysis of laser therapy for the treatment of nonmelanoma skin cancer［J］. Dermatol Surg, 2017,43（5）:615⁃624. doi: 10.1097/DSS.0000000000001048.
［35］	Migden MR, Chang A, Dirix L, et al. Emerging trends in the treatment of advanced basal cell carcinoma［J］. Cancer Treat Rev, 2018,64:1⁃10. doi: 10.1016/j.ctrv.2017.12.009.
［36］	von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature［J］. J Am Acad Dermatol, 1984,10（6）:1043⁃1060. doi: 10.1016/s0190⁃9622（84）80334⁃5.
［37］	Wysong A, Aasi SZ, Tang JY. Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011［J］. JAMA Dermatol, 2013,149（5）:615⁃616. doi: 10.1001/jamadermatol.2013.3064.
［38］	Rowe DE, Carroll RJ, Day CL Jr. Long⁃term recurrence rates in previously untreated （primary） basal cell carcinoma: implications for patient follow⁃up［J］. J Dermatol Surg Oncol, 1989,15（3）:315⁃328. doi: 10.1111/j.1524⁃4725.1989.tb03166.x.
［39］	Rees JR, Zens MS, Gui J, et al. Non melanoma skin cancer and subsequent cancer risk［J］. PLoS One, 2014,9（6）:e99674. doi: 10.1371/journal.pone.0099674.

[1]	王逸飞耿怡缪秋菊宋昊徐秀莲孙建方. 黏蛋白痣10例临床病理分析[J]. 中华皮肤科杂志, 2021, 54(9): 804-807.
[2]	邱月棨付思祺罗帅寒天李亚萍张桂英. 2020年雄激素性脱发的研究进展[J]. 中华皮肤科杂志, 2021, 54(9): 835-838.
[3]	中国医师协会皮肤科医师分会自身免疫性疾病学组. 环磷酰胺治疗自身免疫性皮肤病中国专家共识[J]. 中华皮肤科杂志, 2021, 54(9): 765-770.
[4]	中华医学会医学美学与美容学分会激光美容学组中华医学会皮肤性病学分会美容激光学组中国医师协会美容与整形医师分会激光学组. 中国痤疮瘢痕治疗专家共识（2021）[J]. 中华皮肤科杂志, 2021, 54(9): 747-756.
[5]	郭伟赵涛郭伟楠马翠玲高天文赵建红李冰. 早期甲黑素瘤115例手术治疗方案和预后回顾分析[J]. 中华皮肤科杂志, 2021, 54(9): 777-784.
[6]	王大光蒋佳怡. 几种甲病诊疗的思考[J]. 中华皮肤科杂志, 2021, 54(8): 733-737.
[7]	宋志强顾恒. 加强皮炎湿疹类疾病诊断术语的规范化[J]. 中华皮肤科杂志, 2021, 54(8): 665-667.
[8]	中华医学会皮肤性病学分会皮肤肿瘤研究中心中国医师协会皮肤科医师分会皮肤肿瘤学组. 皮肤鳞状细胞癌诊疗专家共识（2021）[J]. 中华皮肤科杂志, 2021, 54(8): 653-664.
[9]	宋歌梁官钊张美洁董嘉琤刘维达. 毳毛癣的临床诊治进展[J]. 中华皮肤科杂志, 2021, 54(8): 741-743.
[10]	郭丽芳葛一平杨寅林彤. 面部白癜风人工智能诊断模型的建立及评价[J]. 中华皮肤科杂志, 2021, 54(7): 586-589.
[11]	张磊尹盼盼周亚丽段仰灿. 乳房外Paget病的高频彩色多普勒超声特征分析[J]. 中华皮肤科杂志, 2021, 54(7): 625-628.
[12]	虞英媛李影余增洋郑建锋张希琳丁杨峰史玉玲. 英夫利西单抗治疗重度斑块状银屑病的疗效和安全性及其对PD-1、PD-L1表达的影响[J]. 中华皮肤科杂志, 2021, 54(7): 590-596.
[13]	张宇高迎霞顾宁琰朱虹陈京京胡清洁周敏段媛媛姚煦. 奥马珠单抗对慢性自发性荨麻疹患者的临床疗效和安全性分析[J]. 中华皮肤科杂志, 2021, 54(7): 582-585.
[14]	中华医学会皮肤性病学分会银屑病学组中华医学会皮肤性病学分会儿童学组. 中国儿童银屑病诊疗专家共识（2021）[J]. 中华皮肤科杂志, 2021, 54(7): 559-581.
[15]	曹珊杨宝琦. 疱疹样皮炎的研究进展[J]. 中华皮肤科杂志, 2021, 54(6): 549-553.